Q2 2024 Lexicon Pharmaceuticals Inc Earnings Call Transcript
Good day and welcome to the Lexicon Pharmaceuticals second-quarter 2024 financial results conference call. (Operator instructions) Please note this event is being recorded.
I would now like to turn the conference over to Lisa de Francesco, Head Investor Relations and Corporate Strategy. Please go ahead.
Thank you, Betsy. Good afternoon, and welcome to the Lexicon Pharmaceuticals second-quarter 2024 financial results conference call. Joining me today are Dr. Mike Exton, Lexicon's new Chief Executive Officer and Director; Jeff Wade, President and Chief Operating Officer; Tom Garner, Senior Vice President and Chief Commercial Officer; Dr. Craig Granowitz, Senior Vice President and Chief Medical Officer; and Dr. Alan Main, Executive Vice President, Innovation and Chemical Sciences.
Earlier this afternoon, Lexicon issued a press release announcing our financial results for the second quarter of 2024, which is available on our website at
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |